Latest Articles

Article Type

Open Access
New Technologies Bloom Together for Bettering Cancer Drug Conjugates
Yiming Jin, Shahab Edalatian Zakeri, Raman Bahal and Andrew J. Wiemer
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 680-713; DOI: https://doi.org/10.1124/pharmrev.121.000499
Open Access
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Maija Dambrova, Marina Makrecka-Kuka, Janis Kuka, Reinis Vilskersts, Didi Nordberg, Misty M. Attwood, Stefan Smesny, Zumrut Duygu Sen, An Chi Guo, Eponine Oler, Siyang Tian, Jiamin Zheng, David S. Wishart, Edgars Liepinsh and Helgi B. Schiöth
Jukka Hakkola, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 506-551; DOI: https://doi.org/10.1124/pharmrev.121.000408
Open Access
The Nitrogen Mustards
Martin S. Highley, Bart Landuyt, Hans Prenen, Peter G. Harper and Ernst A. De Bruijn
Michael Gottesman, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 552-599; DOI: https://doi.org/10.1124/pharmrev.120.000121
Open Access
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting
Hui Lin, Frank Geurts, Luise Hassler, Daniel Batlle, Katrina M. Mirabito Colafella, Kate M. Denton, Jia L. Zhuo, Xiao C. Li, Nirupama Ramkumar, Masahiro Koizumi, Taiji Matsusaka, Akira Nishiyama, Martin J. Hoogduijn, Ewout J. Hoorn and A.H. Jan Danser
Rhian Touyz, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 462-505; DOI: https://doi.org/10.1124/pharmrev.120.000236
Open Access
Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease
Deborah J. Luessen and P. Jeffrey Conn
Lynette Daws, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 630-661; DOI: https://doi.org/10.1124/pharmrev.121.000540
Open Access
Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders
Gregory Hook, Thomas Reinheckel, Junjun Ni, Zhou Wu, Mark Kindy, Christoph Peters and Vivian Hook
Eric Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 600-629; DOI: https://doi.org/10.1124/pharmrev.121.000527
You have access
Mass Spectrometry Approaches Empowering Neuropeptide Discovery and Therapeutics
Krishna D. B. Anapindi, Elena V. Romanova, James W. Checco and Jonathan V. Sweedler
Vivian Hook, ASSOCIATE EDITOR

Pharmacological Reviews July 2022, 74 (3) 662-679; DOI: https://doi.org/10.1124/pharmrev.121.000423
You have access
Targeting the Adaptive Immune System in Depression: Focus on T Helper 17 Cells
Eléonore Beurel, Eva M. Medina-Rodriguez and Richard S. Jope
Robert Dantzer, ASSOCIATE EDITOR

Pharmacological Reviews April 2022, 74 (2) 373-386; DOI: https://doi.org/10.1124/pharmrev.120.000256
Open Access
Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions
Victoria M. Golub and Doodipala Samba Reddy
Charles France, ASSOCIATE EDITOR

Pharmacological Reviews April 2022, 74 (2) 387-438; DOI: https://doi.org/10.1124/pharmrev.121.000375
Open Access
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, Bruce N. Cronstein and Rodrigo A. Cunha
Eliot Ohlstein, ASSOCIATE EDITOR

Pharmacological Reviews April 2022, 74 (2) 340-372; DOI: https://doi.org/10.1124/pharmrev.121.000445

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals